•
Dec 31, 2022

Avidity Biosciences Q4 2022 Earnings Report

Total Revenue
$2.77M
Previous year: $1.85M
+49.5%
EPS
-$0.88
Previous year: -$0.82
+7.3%
Gross Profit
$2.39M
Previous year: $1.64M
+45.3%
Cash and Equivalents
$340M
Previous year: $320M
+6.2%
Free Cash Flow
-$40M
Previous year: -$27.9M
+43.4%
Total Assets
$639M
Previous year: $428M
+49.4%

Avidity Biosciences

Avidity Biosciences